Clinical Trial Detail

NCT ID NCT02387216
Title A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Merrimack Pharmaceuticals
Indications

non-small cell lung carcinoma

Therapies

Seribantumab

Pemetrexed

Docetaxel

Age Groups: adult

Additional content available in CKB BOOST